K-HUB
Research, Development & Beyond
KHUB, a group of companies including Hanmi Science, is driven by the mission to build a global vaccine hub to ensure global supply and distribution of vaccines against infectious diseases with our professional research and production capabilities.
MEDIA ARCHIVESmore
-
2024 Medical Reformation Think Tank Group MR-TTG
-
European initiative aims to advance the understanding of RNA communication
-
Latest Covid-19 vaccine offers strong protection against symptomatic infection, including from JN.1, early CDC data shows
-
Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?
-
Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trial
-
`mRNA`, 코로나·독감 이어 암까지 정복 나선다
NEWS ROOMmore
-
2024 Medical Reformation Think Tank Group MR-TTG
2024-03-08
-
DXVX "의료 개혁 직접 지원하는 전문 씽크탱크로 성장할 것"
2024-03-04
-
디엑스앤브이엑스, 중국 의약품 제품군 확대…구강염 치료제 출시
2024-02-26
-
DXVX, '코리 헬스케어 4.0' 비대면 진료 서비스 추진
2024-02-01
-
디엑스앤브이엑스(Dx&Vx), 동반진단 CLIDEX 사업 매출 본격화
2024-01-29
-
임종윤 코리그룹 회장 "헬스케어 4.0 혁명" 강조
2024-01-02
-
DXVX, AI 기반 신약개발 기업으로 도약
2023-12-05
-
디엑스앤브이엑스(Dx&Vx), 치료용 항암백신 OVM-200 자체 개발 추진
2023-11-22